Obesity Drug Market in India Grows 10-Fold in 5 Years
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
India's anti-obesity market, now valued at over Rs 1,000 crore, is poised for explosive growth with new drugs and generics. Discover how AI and GLP-1 therapies are transforming healthcare.
Scientists develop novel experimental drugs for obesity by targeting mitochondrial energy production in cells, offering a potential new treatment pathway. Learn about this breakthrough research.
A new German study reveals belly fat silently alters heart structure, raising heart disease risk, especially in men. A cardiologist explains why waist size, not just weight, is critical for Indians.
A 14-year-old from Surat needed a liver transplant due to advanced fatty liver disease, accelerated by junk food and genetic risk. Hepatologists urge urgent action on childhood obesity and diet.
ICMR study reveals disrupted sleep, chronic stress, and central obesity are key drivers of India's rising breast cancer burden, projected to add 50,000 cases yearly. Learn the risk factors.
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
New research reveals GLP-1 drugs like semaglutide offer significant heart, liver, and kidney benefits, transforming treatment for obesity-related conditions. Discover the full scope of their impact.
Emcure Pharmaceuticals launches Poviztra, a weekly semaglutide injection for weight loss, in partnership with Novo Nordisk. Priced from ₹2,200 per week, it targets India's massive obesity market.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
A severe shortage of drug inspectors is hampering enforcement against spurious and adulterated medicines in India. Officials admit the staffing crisis is a major hurdle. Read more on the critical public health issue.
Himachal Pradesh reports the highest number of substandard drug samples in India. 49 samples failed quality tests, raising serious concerns about public health and pharmaceutical regulation.
A new study from Serbia finds most parents fail to recognise when their child is overweight, delaying crucial health interventions. Learn how to spot the signs and take action for your child's long-term wellbeing.
A new World Obesity Atlas warns 51% of the world will be overweight by 2035. Experts highlight higher cardiovascular risk for Asians at lower BMI. Learn about new drugs and safe weight management.
Discover how black cumin (kalonji), a staple in Indian kitchens, is backed by science for improving cholesterol, reducing fat cells, and supporting metabolic health. Learn easy ways to include it in your diet.
The Supreme Court has agreed to hear SAD leader Bikram Singh Majithia's plea for bail in a drugs case. The hearing is scheduled for July 15. Read the latest legal developments.
A landmark UNICEF report reveals a historic shift: more children globally are now obese than underweight. A new scientific review links this crisis and climate change to our food systems. Discover the connection and what we can do.
Karnataka Assembly passes the Drugs and Cosmetics (Amendment) Bill, 2024, enhancing penalties for spurious drug manufacturers and regulating online pharmacy sales. Learn the key changes.
Shark Tank India's Anupam Mittal comments on Ozempic's India launch, its ₹8,800/month price, and the 2026 patent expiry that could 5x the market. Read his take on fitness shortcuts vs. discipline.
Delhi's Drugs Control department sealed a shop & collected 204 samples from 27 wholesale dealers in a major drive against illegal drug trade. Health Minister vows zero tolerance for spurious medicines.
A new Harvard study uncovers how gut microbes signal the liver to influence metabolism, offering a novel holistic approach to managing type 2 diabetes and obesity. Read the breakthrough findings.
Medical experts in Bengaluru link economic growth & globalised fast food to a sharp rise in adolescent obesity, causing PCOD, diabetes & lifelong health issues. Learn the causes and solutions.
New research reveals that smells of fatty foods during pregnancy can rewire a baby's brain, increasing future risks of obesity and diabetes. Learn how to protect your child's health.
A 10-year PGI study finds 19% of Chandigarh residents developed diabetes. Central obesity, a 1.6 cm waist increase, triples risk. Learn how to protect yourself.
Loud snoring in men is often sleep apnea, a serious disorder linked to obesity. It raises risks of heart disease and diabetes. Experts urge timely diagnosis and weight management.
A major Lancet review reveals childhood hypertension has nearly doubled since 2000, affecting 4.3% of kids. Indian experts confirm the surge, linking it to junk food, screens, and stress. Learn the signs and why screening is crucial.
New research reveals popular cooking oils in India may contribute to obesity. Learn which oils are under scrutiny and discover healthier alternatives for your kitchen.
A 10-year-old Mumbai boy gained 10 kg in 5 months due to smartphone addiction. A new US study confirms early smartphone use raises risks of depression, obesity, and poor sleep in children. Learn how a psychologist helped him recover.
WHO releases first-ever global guidelines for GLP-1 medicines to treat obesity, a chronic disease. Learn about the key recommendations and new mental health warnings from Australia.
WHO releases its first global guideline on GLP-1 therapies for obesity, recommending drugs like semaglutide for adults with a BMI over 30. Learn about the impact, safety, and who can benefit.
A new study finds low choline levels in obese young adults may be an early warning for future brain problems like Alzheimer's. Discover the vital nutrient's role and food sources to boost intake.